Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Number of holders
-
23
-
Total 13F principal, excl. options
-
199,068,000
-
Principal change
-
+5,561,208
-
Total reported value, excl. options
-
$199,949,244
-
Value change
-
+$3,671,564
-
Number of buys
-
12
-
Number of sells
-
14
-
Price
-
$1.00
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q1 2023
As of 31 Mar 2023 IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 had 23 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $199,068,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included CITADEL ADVISORS LLC, CAMDEN ASSET MANAGEMENT L P /CA, WOLVERINE ASSET MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, READYSTATE ASSET MANAGEMENT LP, Wellesley Asset Management, Calamos Advisors LLC, JANE STREET GROUP, LLC, TORONTO DOMINION BANK, and SHENKMAN CAPITAL MANAGEMENT INC.
This table shows 23 bond principal holders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.